Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.7 USD | -2.66% | -5.38% | +18.60% |
13/05 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.60% | 205.45Cr | |
-6.01% | 1.2TCr | |
-3.12% | 821.12Cr | |
+7.89% | 580.62Cr | |
+28.68% | 552.91Cr | |
-10.17% | 410.08Cr | |
-60.49% | 264.68Cr | |
+8.52% | 261.08Cr | |
-10.27% | 222.78Cr | |
-8.35% | 178.58Cr |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue